Molecular docking, design, synthesis and antifungal activity study of novel triazole derivatives. 2018

Junqi Wu, and Tingjunhong Ni, and Xiaoyun Chai, and Ting Wang, and Hongrui Wang, and Jindong Chen, and Yongsheng Jin, and Dazhi Zhang, and Shichong Yu, and Yuanying Jiang
Department of Organic Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China; Student Bridge, Second Military Medical University, Shanghai 200433, China.

The incidence of life-threatening fungal infections has dramatically increased for decades. In order to develop novel antifungal agents, two series of (2R,3R)-1-(1H-1,2,4-triazol-1-yl)-2-(2,4-difluorophenyl)-3-(N-substitutied)-2-butanols (3a-o, 5a-f, 8a-u), which were analogues of voriconazole, were designed, synthesized and characterized by 1H NMR, 13C NMR and HRMS. The MIC80 values showed that the target compounds 3a-o indicated better activities than fluconazole on three important fungal pathogens except for 3i. Significant activity of compounds 3d, 3k, 3n, 3m and 3o was observed on the Aspergillus fumigatus strain (MIC80 range: 1-0.125 μg/ml). Especially, compound 3k had strong activity to inhibit the growth of ten fungal pathogens. But it didn't exhibit good activity in in vivo value. Molecular docking experiments demonstrated that 3k possessed superior affinity with target enzyme by strong hydrogen bond from morpholine ring.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D001232 Aspergillus fumigatus A species of imperfect fungi from which the antibiotic fumigatin is obtained. Its spores may cause respiratory infection in birds and mammals. Aspergillus fumigates,Neosartorya fumigata,Sartorya fumigata
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking

Related Publications

Junqi Wu, and Tingjunhong Ni, and Xiaoyun Chai, and Ting Wang, and Hongrui Wang, and Jindong Chen, and Yongsheng Jin, and Dazhi Zhang, and Shichong Yu, and Yuanying Jiang
May 2013, Medicinal chemistry (Shariqah (United Arab Emirates)),
Junqi Wu, and Tingjunhong Ni, and Xiaoyun Chai, and Ting Wang, and Hongrui Wang, and Jindong Chen, and Yongsheng Jin, and Dazhi Zhang, and Shichong Yu, and Yuanying Jiang
July 2011, European journal of medicinal chemistry,
Junqi Wu, and Tingjunhong Ni, and Xiaoyun Chai, and Ting Wang, and Hongrui Wang, and Jindong Chen, and Yongsheng Jin, and Dazhi Zhang, and Shichong Yu, and Yuanying Jiang
November 2018, Molecules (Basel, Switzerland),
Junqi Wu, and Tingjunhong Ni, and Xiaoyun Chai, and Ting Wang, and Hongrui Wang, and Jindong Chen, and Yongsheng Jin, and Dazhi Zhang, and Shichong Yu, and Yuanying Jiang
December 2009, Archiv der Pharmazie,
Junqi Wu, and Tingjunhong Ni, and Xiaoyun Chai, and Ting Wang, and Hongrui Wang, and Jindong Chen, and Yongsheng Jin, and Dazhi Zhang, and Shichong Yu, and Yuanying Jiang
December 2010, Chemical biology & drug design,
Junqi Wu, and Tingjunhong Ni, and Xiaoyun Chai, and Ting Wang, and Hongrui Wang, and Jindong Chen, and Yongsheng Jin, and Dazhi Zhang, and Shichong Yu, and Yuanying Jiang
October 2011, Archives of pharmacal research,
Junqi Wu, and Tingjunhong Ni, and Xiaoyun Chai, and Ting Wang, and Hongrui Wang, and Jindong Chen, and Yongsheng Jin, and Dazhi Zhang, and Shichong Yu, and Yuanying Jiang
November 2023, Journal of agricultural and food chemistry,
Junqi Wu, and Tingjunhong Ni, and Xiaoyun Chai, and Ting Wang, and Hongrui Wang, and Jindong Chen, and Yongsheng Jin, and Dazhi Zhang, and Shichong Yu, and Yuanying Jiang
February 2024, Molecules (Basel, Switzerland),
Junqi Wu, and Tingjunhong Ni, and Xiaoyun Chai, and Ting Wang, and Hongrui Wang, and Jindong Chen, and Yongsheng Jin, and Dazhi Zhang, and Shichong Yu, and Yuanying Jiang
April 2024, Journal of agricultural and food chemistry,
Junqi Wu, and Tingjunhong Ni, and Xiaoyun Chai, and Ting Wang, and Hongrui Wang, and Jindong Chen, and Yongsheng Jin, and Dazhi Zhang, and Shichong Yu, and Yuanying Jiang
January 2017, Chemical & pharmaceutical bulletin,
Copied contents to your clipboard!